Literature DB >> 13871833

Value of serotherapy in a virus disease (rabbit pox).

E A BOULTER, J C WESTWOOD, H B MABER.   

Abstract

Entities:  

Keywords:  SEROTHERAPHY/experimental; VIRUS DISEASES/experimental

Mesh：

Year:  1961        PMID： 13871833     DOI： 10.1016/s0140-6736(61)90969-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Antiserum against smallpox.

Authors: 
Journal:  Br Med J       Date:  1970-11-14

Review 2.  Efficacy of CMX001 as a prophylactic and presymptomatic antiviral agent in New Zealand white rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans.

Authors:  Amanda D Rice; Mathew M Adams; Bernhard Lampert; Scott Foster; Alice Robertson; George Painter; Richard W Moyer
Journal:  Viruses       Date:  2011-02       Impact factor: 5.048

3.  A lethal respiratory infection of rabbits with a strain of Semliki Forest virus (SFV).

Authors:  E A Boulter; I Zlotnik; H B Maber
Journal:  Br J Exp Pathol       Date:  1971-12

4.  Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.

Authors:  Chad J Roy; Thomas G Voss
Journal:  Viruses       Date:  2010-09-27       Impact factor: 5.048

Review 5.  Poxvirus pathogenesis.

Authors:  R M Buller; G J Palumbo
Journal:  Microbiol Rev       Date:  1991-03

6.  Mechanism of recovery from systemic vaccinia virus infection. I. The effects of cyclophosphamide.

Authors:  M Worthington; A S Rabson; S Baron
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.